A15646 | Pages: NA | Jul 2022 | 127 Views | | |
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Duchenne Muscular Dystrophy Market
Request Now !Duchenne muscular dystrophy is a kind of muscular dystrophy. It is a genetic disorder that is characterized by muscle weakness. It is a rare disease that mainly affects males. This condition causes intellectual disability, difficulty in breathing, weakness in muscles, pneumonia, heart failure, mental health disruption, and respiratory failure. This diagnostic care aims to provide individuals with Duchenne muscular dystrophy with accurate and timely therapy.. This type of diagnostic treatment reduces or controls symptoms, but it is not curable . Drugs such as steroids are used to reduce symptoms of duchenne muscular dystrophy and stem cell therapy and gene therapy are also used for its treatment.
Market Scope and Structure Analysis
Report Metric | Details |
Market Size Available for Years | 2020–2030 |
Base Year Considered | 2020 |
Forecast Period | 2021–2030 |
Forecast Unit | Value (USD) |
Segments Covered | Product Type, Application, End User, and Region |
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. This highly contagious disease, caused by a virus , is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is transmitted from one person to another. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a pandemic on March 11, 2020.
Pharmaceutical and biotech companies along with governments across the globe work to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. According to NCBI, out of 116 duchenne muscular dystrophy patients one patient found to be positive for Covid-19 infection. Moreover, commonly used drugs such as Corticosteroids have witnessed a dramatic increase in demand for the management of patients with duchenne muscular dystrophy with COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as there is a shortage of these drugs in many developed countries. Thus, the pharmaceutical and biotechnology industry is expected to experience a significant growth in the future owing to the demand for corticosteroids drugs for COVID-19. This in turn is expected to have a significant impact on the duchenne muscular dystrophy market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish the Market
In February 2021, Sarepta Therapeutics has received DA approval for Amondys 45 (casimersen injection), it is an antisense oligonucleotide for the treatment of Duchenne Muscular Dystrophy patients.
In August 2020, NS Pharma, Inc. launched Viltepso (viltolarsen injection) for the treatment of DMD patients who confirmed mutation of Duchenne Muscular Dystrophy gene which is amenable to skipping of exon 53.
In December 2019, Tahio Pharmaceutical launched TAS-205, it is hematopoietic prostaglandin D synthase (HPGDS) inhibitor for the treatment of DMD. TAS-205 exacerbates the inflammatory response in patients of DMD.
Key Benefits of the Report
Questions Answered in the Duchenne Muscular Dystrophy Report
Key Market Segments
Segments | Sub-segments |
---|---|
By Product Type |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers